Literature DB >> 23436051

Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.

A J Degnan1, L M Levy.   

Abstract

Most dementias begin insidiously, developing slowly and generally occurring in the elderly age group. The so-called rapidly progressive dementias constitute a different, diverse collection of conditions, many of which are reversible or treatable. For this reason, prompt identification and assessment of acute and subacute forms of dementia are critical to effective treatment. Numerous other entities within this category of presenile rapid-onset dementias are untreatable such as the prion-related diseases. Neuroimaging aids in the diagnosis and evaluation of many of these rapidly progressive dementias, which include myriad conditions ranging from variations of more common neurodegenerative dementias, such as Alzheimer disease, dementia with Lewy bodies, and frontotemporal dementia; infectious-related dementias such as acquired immune deficiency syndrome dementia; autoimmune and malignancy-related conditions; to toxic and metabolic forms of encephalopathy. This first of a 2-part review will specifically address the ability of MR imaging and ancillary neuroimaging strategies to support the diagnostic evaluation of rapidly progressive dementias due to neurodegenerative causes.

Entities:  

Mesh:

Year:  2013        PMID: 23436051      PMCID: PMC7964711          DOI: 10.3174/ajnr.A3454

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  51 in total

1.  Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Michael J Firbank; Andrew M Blamire; Andrew Teodorczuk; Emma Teper; Dipayan Mitra; John T O'Brien
Journal:  Psychiatry Res       Date:  2011-09-29       Impact factor: 3.222

2.  Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

Authors:  Giuseppe Nicoletti; Raffaele Lodi; Francesca Condino; Caterina Tonon; Francesco Fera; Emil Malucelli; David Manners; Mario Zappia; Letterio Morgante; Paolo Barone; Bruno Barbiroli; Aldo Quattrone
Journal:  Brain       Date:  2006-06-30       Impact factor: 13.501

Review 3.  Magnetic resonance imaging in lewy body dementias.

Authors:  Rosie Watson; Andrew M Blamire; John T O'Brien
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-08       Impact factor: 2.959

4.  Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.

Authors:  N Z Hobbs; J Barnes; C Frost; S M D Henley; E J Wild; K Macdonald; R A Barker; R I Scahill; N C Fox; S J Tabrizi
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

5.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

6.  Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.

Authors:  Kejal Kantarci; Stephen D Weigand; Ronald C Petersen; Bradley F Boeve; David S Knopman; Jeffrey Gunter; Denise Reyes; Maria Shiung; Peter C O'Brien; Glenn E Smith; Robert J Ivnik; Eric G Tangalos; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2006-07-24       Impact factor: 4.673

7.  Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia.

Authors:  Emma J Burton; Elizabeta B Mukaetova-Ladinska; Robert H Perry; Evelyn Jaros; Robert Barber; John T O'Brien
Journal:  Neurobiol Aging       Date:  2011-02-24       Impact factor: 4.673

Review 8.  Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.

Authors:  Klaus Seppi; Werner Poewe
Journal:  Neuroimaging Clin N Am       Date:  2010-02       Impact factor: 2.264

9.  MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.

Authors:  Caroline K Jurgens; Radu Jasinschi; Ahmet Ekin; Marie-Noëlle W Witjes-Ané; Huub Middelkoop; Jeroen van der Grond; Raymund A C Roos
Journal:  PLoS Curr       Date:  2010-09-08

10.  Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.

Authors:  Dominic C Paviour; Shona L Price; Marjan Jahanshahi; Andrew J Lees; Nick C Fox
Journal:  Brain       Date:  2006-02-02       Impact factor: 13.501

View more
  7 in total

1.  Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.

Authors:  Mariel B Deutsch; Mario F Mendez
Journal:  Cogn Behav Neurol       Date:  2015-03       Impact factor: 1.600

Review 2.  Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis.

Authors:  B P Kelley; S C Patel; H L Marin; J J Corrigan; P D Mitsias; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

Review 3.  Rapidly progressive dementias - aetiologies, diagnosis and management.

Authors:  Peter Hermann; Inga Zerr
Journal:  Nat Rev Neurol       Date:  2022-05-04       Impact factor: 44.711

4.  Development of a New Index to Distinguish Hepatic Encephalopathy through Automated Quantification of Globus Pallidal Signal Intensity Using MRI.

Authors:  Yasuyuki Tamai; Motoh Iwasa; Yuichi Yoshida; Jun Nomoto; Takahiro Kato; Hiroe Asuke; Akiko Eguchi; Yoshiyuki Takei; Hayato Nakagawa
Journal:  Diagnostics (Basel)       Date:  2022-06-29

5.  Rapidly progressive dementia: An eight year (2008-2016) retrospective study.

Authors:  Patil Anuja; Vishnu Venugopalan; Naheed Darakhshan; Pandit Awadh; Vinny Wilson; Goyal Manoj; Modi Manish; Lal Vivek
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

6.  Spectrum of noncerebrovascular rapidly progressive cognitive deterioration: a 2-year retrospective study.

Authors:  Yun Zhang; Ting Gao; Qing-Qing Tao
Journal:  Clin Interv Aging       Date:  2017-10-09       Impact factor: 4.458

7.  18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis.

Authors:  Cornelius Deuschl; Theodor Rüber; Leon Ernst; Wolfgang P Fendler; Julian Kirchner; Christoph Mönninghoff; Ken Herrmann; Carlos M Quesada; Michael Forsting; Christian E Elger; Lale Umutlu
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.